From: msu.edu Why this matters: These new chemicals provide targeted therapy to cancer cells while sparing healthy cells. This therapy provides new opportunities for delivering drugs to other types of cancers. Typically, patients using photodynamic therapy must limit their sun exposure during and after treatment. These new chemicals flush out of the body faster. A wife and husband professor team …
Mammograms for Breast Cancer Screening
From: healthline.com Mammograms can catch early signs of breast cancer. If you’re a woman between the ages of 40 and 74, it’s recommended to get a screening every other year. But men may also need to get screened. A mammogram is a special type of X-ray used to scan breast tissue. It may be used as either a screening tool …
Omega-6 Fatty Acid Promotes the Growth of an Aggressive Type of Breast Cancer
From: cornell.edu Linoleic acid, an omega-6 fatty acid found in seed oils such as soybean and safflower oil, and animal products including pork and eggs, specifically enhances the growth of the hard-to-treat “triple negative” breast cancer subtype, according to a preclinical study led by Weill Cornell Medicine investigators. The discovery could lead to new dietary and pharmaceutical strategies against breast …
NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies
By: Luke Halpern, Assistant Editor From: pharmacytimes.com Key Takeaways Advancements in BC risk assessment are essential due to rising incidence, especially in younger women, with genetic and modifiable factors playing key roles. Multiple BC risk models exist, each with unique assessment domains and limitations, requiring combined use for effective patient guidance. Standard BC prevention methods include enhanced screening, risk-reducing therapies, …
Almost All Women With Breast Cancer Are Also Vitamin D Deficient
By: Morgan Chamberlain From: mindbodygreen.com We all know someone who’s been affected by breast cancer, so it shouldn’t come as a surprise that it’s the most common type of cancer worldwide. According to a 2022 review published in The Breast, breast cancer accounts for one in eight cancer diagnoses and resulted in a total of 2.3 million new cases in …
8 Disproven Breast Cancer Risk Factors You Need to Know
By: Joni Sweet From: bcrf.org BCRF separates fact from fiction on eight controversial, disproven breast cancer risk factors—and shares what science actually says about risk and certain lifestyle choices While it’s normal to consider whether everyday habits could raise your risk, the good news is that many commonly cited dangers have been debunked. Here, BCRF separates fact from fiction by …
Three out of ten breast cancers detected between screenings, study finds
By Anna Björklund, Karolinska Institutet From: medicalxpress.com In a new study, researchers from Karolinska Institutet have shown that so-called interval cancers, which are detected between two screening sessions, account for a significant proportion of breast cancer cases and that certain risk factors may increase the likelihood of developing this type of cancer. The study was published in the journal JAMA …
Study reveals progressive breast shrinkage after breast-conserving therapy
Source: Wolters Kluwer From: news-medical.net For women with early-stage breast cancer, breast-conserving therapy (BCT) including radiation therapy (RT) leads to progressive reduction in breast size over time, reports a study in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). The journal is published in the Lippincott portfolio by Wolters Kluwer. New data on …
Aromatase Inhibitors Show Greater Benefit in Preventing Contralateral Breast Cancer
By: Alexandra Gerlach, Associate Editor From: pharmacytimes.com Key Takeaways Endocrine therapy reduces CBC risk, especially in ER+/HER2- breast cancer, with aromatase inhibitors being more effective than tamoxifen. Longer therapy durations, particularly 10-year aromatase inhibitor regimens, significantly decrease CBC cases, with younger women benefiting most. The study highlights the importance of personalized treatment plans, considering age, side effects, and adherence to …
Researchers Identify Key Signaling Pathway Disruptions Driving Breast Cancer Treatment Resistance
By: Alexandra Gerlach, Associate Editor From: pharmacytimes.com Key Takeaways Disruptions in PI3K/Akt/mTOR signaling pathways drive oncogenesis and treatment resistance in breast cancer, affecting 25%-40% of cases. Dysregulation of cellular signaling pathways, including PI3K/Akt/mTOR and RAS/RAF/MEK/ERK, promotes tumor growth and therapy resistance. Emerging treatments focus on targeted therapies, immunotherapies, and novel drug delivery systems to improve precision targeting and overcome resistance. …